Related Experiment Video

Updated: Sep 26, 2026

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

Nitric oxide and cardiovascular protection

Bodh I Jugdutt1

  • 1Walter Mackenzie Health Sciences Center, Cardiology Division, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. bjugdutt@ualberta.ca

Heart Failure Reviews
|March 26, 2003
PubMed

Insights

Nitric oxide (NO) is vital for protecting the heart during ischemia-reperfusion injury. Its role in triggering late ischemic preconditioning (IPC) may offer new therapeutic strategies for heart disease.

Area of Science:

  • Cardiovascular Science
  • Molecular Medicine
  • Pharmacology

Background:

  • Nitric oxide (NO) is increasingly recognized for its protective functions in myocardial and vascular tissues, particularly in the context of ischemic heart disease and ischemia-reperfusion.
  • Understanding the mechanisms of NO signaling is crucial for developing effective treatments for heart conditions.

Purpose of the Study:

  • To explore the potential role of nitric oxide (NO) as a trigger for late ischemic preconditioning (IPC).
  • To investigate the involvement of NO signaling in the cardioprotective effects of ACE inhibitors and angiotensin II type 1 receptor (AT(1)) antagonists.

Main Methods:

  • Review of existing evidence on nitric oxide's role in cardiovascular protection.
  • Analysis of studies investigating ischemic preconditioning mechanisms.
  • Examination of research on the interaction between NO, ACE inhibitors, and AT(1) receptor antagonists.

Main Results:

  • Growing evidence suggests nitric oxide (NO) contributes significantly to myocardial and vascular protection.
  • Emerging findings indicate that NO may act as a key trigger for late ischemic preconditioning (IPC).
  • The interplay between NO signaling and the efficacy of cardiovascular drugs like ACE inhibitors and AT(1) antagonists is an active research focus.

Conclusions:

  • Nitric oxide (NO) is a critical mediator in cardiovascular protection during ischemic events.
  • The potential of NO to trigger late ischemic preconditioning (IPC) opens avenues for novel anti-ischemic therapies.
  • Further research into NO signaling pathways is essential for optimizing treatments for ischemic heart disease.

More Related Videos

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Preparation of Rat Skeletal Muscle Homogenates for Nitrate and Nitrite Measurements07:19

Preparation of Rat Skeletal Muscle Homogenates for Nitrate and Nitrite Measurements

Published on: July 29, 2021

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...